These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 6128316)

  • 21. Intrauterine devices: an effective alternative to oral hormonal contraception.
    Prescrire Int; 2009 Jun; 18(101):125-30. PubMed ID: 19637436
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Long-term cytologic studies of copper-IUD users.
    Engineer AD; Misra JS; Tandon P
    Acta Cytol; 1981; 25(5):550-6. PubMed ID: 6945020
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The morphometric study of endometrial spiral arterioles before and after insertion of gamma CuI and TCu 220C intrauterine devices].
    Liu Z; Chen Q; Ni X
    Zhonghua Fu Chan Ke Za Zhi; 1998 Apr; 33(4):232-4. PubMed ID: 10682472
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intrauterine devices and intrauterine systems.
    ESHRE Capri Workshop Group
    Hum Reprod Update; 2008; 14(3):197-208. PubMed ID: 18400840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparative study on contraceptive efficacy and clinical performance of the copper/low-density polyethylene nanocomposite IUD and the copper T220C IUD.
    Yu J; Li J; Li HG; Li JX; Xie CS; Zhu CH
    Contraception; 2008 Oct; 78(4):319-23. PubMed ID: 18847581
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Effects of long-term installation of intrauterine devices on intrauterine microenvironment].
    Dong BH; Hou GH; Zhang YZ; Fan J; Zhang P; Li L; Luo X
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(10):823-6. PubMed ID: 12895331
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Nova-T 200 intrauterine contraceptive device: a 12 year study.
    Baeyertz JD; Hartfield VJ
    N Z Med J; 1997 May; 110(1043):169-71. PubMed ID: 9196502
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of dysfunctional uterine bleeding: patient preferences for endometrial ablation, a levonorgestrel-releasing intrauterine device, or hysterectomy.
    Bourdrez P; Bongers MY; Mol BW
    Fertil Steril; 2004 Jul; 82(1):160-6, quiz 265. PubMed ID: 15237006
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hysterographic orientation of IUDs in relation to menstrual blood loss.
    Kandil O; Aref I; El-sheikha Z; Radwan MM; El-agizi H; Hassanein MK
    Contracept Deliv Syst; 1983 Jul; 4(3):213-7. PubMed ID: 12265365
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [An analysis of complications and bacteriological and histological studies following extraction of an intrauterine contraceptive device (Beospir) which was inserted several years ago].
    Kracunović M; Oprić M
    Jugosl Ginekol Opstet; 1980; 19(3-4):191-4. PubMed ID: 7412377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison between two IUDs: Progestasert and CuT 200.
    Larsen S; Hansen MK; Jacobsen JC; Ladehoff P; Sorensen T; Westergaard JG
    Contracept Deliv Syst; 1981 Oct; 2(4):281-6. PubMed ID: 12336988
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Endometrial cytology of IUD smears: endometrial reaction study].
    Salome N; Rezende CD; Peixoto RM; Rocha AH
    J Bras Ginecol; 1986; 96(6):263-6. PubMed ID: 12268684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Management of abnormal bleeding in an intrauterine device user].
    Desmons F; Adam-steen C
    Cah Sexol Clin; 1985; 11(63):185-7. PubMed ID: 12281357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intrauterine release of progesterone. II. Modification of macromolecular synthesis of endometrium.
    Hernandez O; Ballesteros LM; Aznar R; Delgado NM; Rosado A
    Contracept Deliv Syst; 1981 Oct; 2(4):319-25. PubMed ID: 12336993
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Three dimensional reconstruction of human endometrial spiral arteries preinsertion and postinsertion of IUD].
    Huang L; Chen L; Chen Q
    Zhonghua Fu Chan Ke Za Zhi; 1996 Sep; 31(9):523-5. PubMed ID: 9275421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fibrinolytic activity of menstrual blood in normal and menorrhagic women and in women wearing the Lippes Loop and the Cu-T (200).
    Hefnawi F; Saleh A; Kandil O; El-Sheikha Z; Hassanein M; Askalani H
    Int J Gynaecol Obstet; 1979; 16(5):400-7. PubMed ID: 35409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Release of copper from intrauterine contraceptive devices Copper T-200].
    Goluda M; Lembas J
    Wiad Lek; 1985 Jul; 38(13):933-6. PubMed ID: 4060722
    [No Abstract]   [Full Text] [Related]  

  • 40. Plasminogen activators in the endometrium of women using intrauterine contraceptive devices.
    Kasonde JM; Bonnar J
    Br J Obstet Gynaecol; 1976 Apr; 83(4):315-9. PubMed ID: 1268139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.